167 related articles for article (PubMed ID: 33298901)
1. BMP signaling is a therapeutic target in ovarian cancer.
Fukuda T; Fukuda R; Tanabe R; Koinuma D; Koyama H; Hashizume Y; Moustakas A; Miyazono K; Heldin CH
Cell Death Discov; 2020 Dec; 6(1):139. PubMed ID: 33298901
[TBL] [Abstract][Full Text] [Related]
2. Tumor Promoting Effect of BMP Signaling in Endometrial Cancer.
Fukuda T; Fukuda R; Miyazono K; Heldin CH
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360647
[TBL] [Abstract][Full Text] [Related]
3. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
[TBL] [Abstract][Full Text] [Related]
4. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.
Peng J; Yoshioka Y; Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Kharma B; Murakami R; Abiko K; Murphy SK; Konishi I
Mol Carcinog; 2016 Apr; 55(4):335-45. PubMed ID: 25663289
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-508 suppresses epithelial-mesenchymal transition, migration, and invasion of ovarian cancer cells through the MAPK1/ERK signaling pathway.
Hong L; Wang Y; Chen W; Yang S
J Cell Biochem; 2018 Sep; 119(9):7431-7440. PubMed ID: 29781537
[TBL] [Abstract][Full Text] [Related]
6. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
7. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
8. Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion.
Kang MH; Kang HN; Kim JL; Kim JS; Oh SC; Yoo YA
Oncol Rep; 2009 Sep; 22(3):525-34. PubMed ID: 19639199
[TBL] [Abstract][Full Text] [Related]
9. Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells.
Thibault B; Jean-Claude B
J Ovarian Res; 2017 Apr; 10(1):31. PubMed ID: 28446239
[TBL] [Abstract][Full Text] [Related]
10. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
12. The BMP signaling pathway enhances the osteoblastic differentiation of bone marrow mesenchymal stem cells in rats with osteoporosis.
Zhao B; Xing G; Wang A
J Orthop Surg Res; 2019 Dec; 14(1):462. PubMed ID: 31870454
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin signaling pathway.
Tian H; Zhou T; Chen H; Li C; Jiang Z; Lao L; Kahn SA; Duarte MEL; Zhao J; Daubs MD; Buser Z; Brochmann EJ; Wang JC; Murray SS
J Orthop Res; 2019 Jul; 37(7):1638-1648. PubMed ID: 30737824
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells.
Mihajlović J; Diehl LAM; Hochhaus A; Clement JH
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2675-2687. PubMed ID: 31531741
[TBL] [Abstract][Full Text] [Related]
15. BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK.
Beck SE; Jung BH; Del Rosario E; Gomez J; Carethers JM
Cell Signal; 2007 Jul; 19(7):1465-72. PubMed ID: 17317101
[TBL] [Abstract][Full Text] [Related]
16. The BMP2 antagonist inhibitor L51P enhances the osteogenic potential of BMP2 by simultaneous and delayed synergism.
Khattab HM; Ono M; Sonoyama W; Oida Y; Shinkawa S; Yoshioka Y; Maekawa K; Tabata Y; Sugama K; Sebald W; Kuboki T
Bone; 2014 Dec; 69():165-73. PubMed ID: 25240457
[TBL] [Abstract][Full Text] [Related]
17. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J
J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520
[TBL] [Abstract][Full Text] [Related]
18. Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells.
Ceccarelli S; Megiorni F; Bellavia D; Marchese C; Screpanti I; Checquolo S
Stem Cells Int; 2019; 2019():6264931. PubMed ID: 30723507
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
